Hopec Pharma
Immunotherapy Treatment for Bladder Cancer
Active
Seed
Startup
Giv'at Shmuel
Founded 2023-02
Hopec Pharma is transforming the treatment of Non-Muscle Invasive Bladder Cancer (NMIBC) with HOPEC (UPEC-FimON), an innovative non-intravesical immunotherapy invented by Prof. Gilad Bachrach, Prof. Chamutal Gur, Prof. Ofer Mandelboim, and Dr. Vladimir Yutkin from the Hebrew University of Jerusalem and Hadassah Medical Center. This genetically modified Urop…
SectorHealth Tech & Life Sciences
StageSeed
Total raised$4.0M
Employees5
Founded2023-02
HQGiv'at Shmuel
Patents1
Confidence80
Sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technology
BiologicalsMicroorganisms
Target customers
Healthcare & Life SciencesHealthcarePatientsLife SciencesPharmaceuticalsBiotechnology